SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mannarino, E.
Right arrow Articles by Orlandi, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mannarino, E.
Right arrow Articles by Orlandi, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effect of Buflomedil Chlorhydrate on Local Oxygen Delivery in Peripheral Vascular Disease

E. Mannarino

Angiology Section, Dept. of Internal Medicine, University of Perugia, Perugia, Italy

L. Pasqualini

Angiology Section, Dept. of Internal Medicine, University of Perugia, Perugia, Italy

G. Maragoni

Angiology Section, Dept. of Internal Medicine, University of Perugia, Perugia, Italy

U. Orlandi

Angiology Section, Dept. of Internal Medicine, University of Perugia, Perugia, Italy

Modifications in transcutaneous oxygen pressure (TcPO2), induced by the administration of 3 mg/kg/day buflomedil chlorhydrate for seven days were evaluated in 12 subjects suffering from peripheral vascular disease (PVD). After the treatment a significant increase in TcPO 2 basal values was observed in Stage III and Stage IV PVD patients (+32.2%) while a significant reduction of 12 % in the half-recovery time to basal val ues after an induced ischemia was re corded in Stage II PVD patients by the seventh day. Buflomedil did not, however, cause any significant varia tions in the ankle/arm pressure ratio or in the plethysmographic peak flow.

Angiology, Vol. 40, No. 6, 559-562 (1989)
DOI: 10.1177/000331978904000607


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement